Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever

    Marina Belia, Asimina Papanikolaou, Panagiotis Skendros, Theodoros Vassilakopoulos
    e2022059
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.059
    994
    PDF: 519
    HTML: 301
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    4954
    PDF: 1997
    HTML: 8435
  • Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.

    Stefano Fratoni, Pasquale Niscola, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Edoardo Mercadante, Andrea Casullo, Paolo de Fabritiis, Alessio Perrotti, Giuseppe Santeusanio
    e2013013
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.013
    1356
    PDF: 720
    HTML: 1968
  • Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab: a Case Report

    Pier Luigi Zinzani, Flavia Salvatore, Beatrice Casadei, Camilla Mazzoni, Marianna Gentilini, Giulia Gabrielli, Lisa Argnani
    e2026052
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.052
    269
    PDF: 111
    HTML: 30
  • IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

    İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
    e2022074
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.074
    1587
    PDF: 806
    HTML: 222
  • Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

    Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo
    e2019057
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.057
    1605
    PDF: 975
    HTML: 264
  • A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery

    Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri
    e2023063
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.063
    694
    PDF: 421
    HTML: 143
  • Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas

    Safaa M. Ramadan
    e2021018
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.018
    1139
    PDF: 392
    HTML: 241
  • T-cell Large Granular Lymphocytic Leukemia Manifesting in Patients with HIV-1 Infection: Cases Series and Review of the Literature

    Ashley M Rose, Leidy Isenalumhe, Magali VanDenBergh, Lubomir Sokol
    e2018036
    2018-06-21
    https://doi.org/10.4084/mjhid.2018.036
    2592
    PDF: 943
    HTML: 331
  • INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

    Giuseppe La Torre
    e2016044
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.044
    4741
    PDF: 1504
    HTML: 3164
  • TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Marta Muzio, Eleonora Fonte, Federico Caligaris-Cappio
    e2012055
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.055
    2627
    PDF: 887
    HTML: 17577
    Fig1 Caligaris: 184
    Fig.2 Caliga: 229
  • PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

    Mario Sabatelli, Luca Laurenti, Marco Luigetti
    e2018057
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.057
    1787
    PDF: 889
    HTML: 388
    Fig1: 244
    Fig.2: 260
    Fig. 3: 193
    Fig. 5: 207
    Fig. 4: 233
  • CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL

    Abdolreza Sotoodeh Jahromi, Mohammad Kargar, Farshid Kafilzadeh, Marzieh Jamalidoust, Maliheh Moradzadeh
    e2021049
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.049
    1316
    PDF: 508
    HTML: 208
  • EVOLVING DISEASE SPECTRUM AND CHARACTERISTICS OF PEOPLE WITH HIV IN EASTERN CHINA: A 12-YEAR STUDY

    Ye Xiong, Bohao Dai, Dairong Xiang, Jean-Pierre Routy, Biao Zhu
    e2025077
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.077
    502
    PDF: 231
    Html: 54
  • Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

    Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri
    e2022042
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.042
    904
    PDF: 428
    HTML: 207
  • INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

    Livio Pagano, Davide Facchinelli, Dr.
    e2018063
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.063
    2084
    PDF: 1131
    HTML: 229
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    2148
    PDF: 1075
    HTML: 1211
  • Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

    Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.029
    442
    PDF: 383
    HTML: 102
  • THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

    Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra
    e2011031
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.031
    2313
    PDF: 960
    HTML: 2398
  • Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

    Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo
    e2009001
    2009-06-22
    3361
    PDF: 588
    HTML: 675
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3543
    PDF: 1659
    HTML: 7932
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2508
    PDF: 801
    HTML: 1742
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5307
    PDF: 1961
    HTML: 1383
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1681
    PDF: 660
    HTML: 2437
  • THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

    Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso
    e2023064
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.064
    1409
    PDF: 863
    HTML: 143
  • MANAGEMENT OF LATENT TUBERCULOSIS INFECTION BASED ON T-SPOT.TB ASSAY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

    Emrah Kiliacaslan, Kadir Canoglu
    e2023003
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.003
    1524
    PDF: 1132
    HTML: 487
  • MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

    Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh
    e2025032
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.032
    865
    PDF: 882
    HTML: 130
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1051
    PDF: 1001
    HTML: 158
  • Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

    Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola
    e2026059
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.059
    115
    PDF: 85
    HTML: 7
  • Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

    Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile
    e2023061
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.061
    851
    PDF: 440
    HTML: 122
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2383
    PDF: 1029
    HTML: 2086
  • JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.

    jean elcheikh
    e2012043
    2012-06-20
    https://doi.org/10.4084/mjhid.2012.043
    1138
    PDF: 848
    HTML: 10943
  • ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

    Soner Solmaz
    e2016019
    2016-03-01
    https://doi.org/10.4084/mjhid.2016.019
    3058
    PDF: 991
    HTML: 1571
  • A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

    Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo
    e2025033
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.033
    897
    PDF: 716
    HTML: 193
  • HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

    Michele Bibas, Gianluigi Biava, Andrea Antinori
    e2011030
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.030
    4064
    PDF: 1500
    HTML: 8524
  • Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

    Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.030
    497
    PDF: 403
    HTML: 154
  • MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS

    Mrinalini kotru, Deepti Mutereja, Abhishek Purohit, Seema Tyagi, Manoranjan Mahapatra, Renu Saxena, Hara Prasad Pati
    e2016049
    2016-10-17
    https://doi.org/10.4084/mjhid.2016.049
    3354
    PDF: 735
    HTML: 724
    Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 191
    Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 192
    Table : Distribution of the sites of bleeding and their causes: 189
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    2563
    PDF: 958
    HTML: 309
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

    Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
    e2012069
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.069
    2587
    PDF: 743
    HTML: 1535
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    1742
    PDF: 1144
    HTML: 296
  • INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.

    Corrado Girmenia, Erica Finolezzi, Vincenzo Federico
    e2011013
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.013
    2309
    PDF: 987
    HTML: 1863
  • LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

    Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
    e2020020
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.020
    1813
    PDF: 1187
    HTML: 258
  • WHO HAS THERAPY-RELATED AML?

    Robert Gale, John M. Bennett, F. Owen Hoffman
    e2017025
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.025
    3182
    PDF: 4328
    HTML: 811
  • DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

    Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes
    e2020016
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.016
    1905
    PDF: 1081
    HTML: 375
  • Immune thrombocytopenic purpura cases following COVID-19 vaccination.

    Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida
    e2021047
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.047
    1137
    PDF: 448
    HTML: 328
51 - 95 of 95 items << < 1 2 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.